Interstitial deletion of 20q in a patient with Waldenström macroglobulinemia following chemotherapy.
A 76-year-old male with a history of renal insufficiency was found to have anemia, an IgM kappa paraprotein on serum immunofixation studies, absence of lytic bone lesions, and findings in the bone marrow consistent with Waldenström macroglobulinemia (WM). Cytogenetic studies including fluorescence in situ hybridization (FISH) on the post-treatment bone marrow revealed the karyotype 46,XY,del(20)(q13.1q13.3). Less than 70 cases of karyotypic abnormalities in patients with WM have been reported, which have shown no abnormalities specific to WM. Monosomy or trisomy of chromosome 20 has been reported in approximately eight cases, but to our knowledge this is the first case report of an interstitial deletion of 20q, confirmed by FISH using chromosome 20 subtelomeric specific probes. Interstitial deletions of 20q are known to occur in polycythemia vera and other hematological malignancies, especially those of myeloid origin.
Blann
Melissa M
MM
Department of Pathology, Texas Tech Medical Center, Lubbock, TX, USA.
Velagaleti
Gopalrao V N
GV
Morgan
David L
DL
Martinez
Rodolfo E
RE
Conlin
Phillip A
PA
Tonk
Vijay S
VS
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002872:Chromosome Deletion; D002890:Chromosomes, Human, Pair 20; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy* / Q000235:genetics*
D000970:Antineoplastic Agents